Ignite Creation Date:
2025-12-25 @ 2:15 AM
Ignite Modification Date:
2025-12-26 @ 6:07 PM
Study NCT ID:
NCT01581060
Status:
TERMINATED
Last Update Posted:
2014-05-16
First Post:
2012-03-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I/II Dose-escalation Study to Investigate Safety and Pharmacokinetics/ Pharmacodynamics of WX-554 in Patients With Solid Tumours
Sponsor:
Heidelberg Pharma AG
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-03
Start Date Type:
None
Primary Completion Date:
2014-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-04
Completion Date Type:
ACTUAL
First Submit Date:
2012-03-28
First Submit QC Date:
None
Study First Post Date:
2012-04-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-05-15
Last Update Post Date:
2014-05-16
Last Update Post Date Type:
ESTIMATED